Efficacy and Safety of DA-3002 in Short Children Borns SGA.

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 26, 2016

Primary Completion Date

August 28, 2019

Study Completion Date

August 28, 2019

Conditions

Infant, Small for Gestational Age

Interventions

DRUG

DA-3002

DRUG

Genotropin®

Trial Locations (1)

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02770157 - Efficacy and Safety of DA-3002 in Short Children Borns SGA. | Biotech Hunter | Biotech Hunter